You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SGLT2 inhibition; dapagliflozin

Showing 1 - 25 of 3,464
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Failure, Hemodialysis, Diabetes, Type 2 Trial (Dapagliflozin 10 MG, Placebo)

Not yet recruiting
  • Kidney Failure
  • +4 more
  • Dapagliflozin 10 MG
  • Placebo
  • (no location specified)
Aug 23, 2022

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Dapagliflozin, BIOSENSE meters)

Completed
Has Results
  • Pancreas Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 20, 2022

Type 2 Diabetes, Hypertension Trial in New Orleans (Dapagliflozin, Sulfonylurea, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Hypertension
  • New Orleans, Louisiana
    Tulane University
Oct 5, 2022

Type 2 Diabetes, Myocardial Fibrosis, Myocardial Inflammation Trial in Seattle (dapagliflozin, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • +2 more
  • Seattle, Washington
    University of Washington
Jan 9, 2023

Type2diabetes, PreDiabetes, Renal Failure Trial in Duesseldorf, Heidelberg (Dapagliflozin (Forxiga®), Placebo matching

Not yet recruiting
  • Type2diabetes
  • +2 more
  • Dapagliflozin (Forxiga®)
  • +2 more
  • Duesseldorf, Germany
  • +1 more
Sep 18, 2023

Heart Attack, Enlarged Heart Trial in Minneapolis (Dapagliflozin, Placebo)

Recruiting
  • Heart Attack
  • Enlarged Heart
  • Minneapolis, Minnesota
    Minneapolis Heart Institute Foundation
Aug 4, 2022

Chronic Renal Failure, Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis

Recruiting
  • Chronic Renal Failure
  • Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
  • Dapagliflozin 10mg Tab
  • +5 more
  • Marseille, France
  • +1 more
May 23, 2023

Diabetes, Type 1 Trial in Bern (Forxiga 10mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Forxiga 10mg
  • Placebo
  • Bern, Switzerland
    Department of Diabetes, Endocrinology, Nutritional Medicine and
Nov 7, 2022

Prostate Cancer, Cancer of Prostate Trial in Saint Louis (Dapagliflozin, BIOSENSE Meter)

Not yet recruiting
  • Prostate Cancer
  • Cancer of Prostate
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 19, 2021

Acute Kidney Injury, Cardiac Surgery, Sodium-Glucose Transporter 2 Inhibitor Trial in Netherlands (Dapagliflozin 10 MG Oral

Not yet recruiting
  • Acute Kidney Injury
  • +2 more
  • Dapagliflozin 10 MG Oral Tablet [Farxiga]
  • Placebo
  • Amsterdam, Netherlands
  • +5 more
Oct 18, 2022

Aging Trial in San Antonio (Dapagliflozin 10 mg, Nutritional counseling)

Recruiting
  • Aging
  • Dapagliflozin 10 mg
  • Nutritional counseling
  • San Antonio, Texas
  • +1 more
Dec 23, 2021

Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Placebo
  • +3 more
  • San Antonio, Texas
    University Health System Texas Diabetic Institute
Apr 28, 2022

Type 2 Diabetes, Obesity Trial in Amsterdam (Dapagliflozin 10mg, Exenatide, exenatide)

Completed
  • Type 2 Diabetes Mellitus
  • Obesity
  • Dapagliflozin 10mg
  • +3 more
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VU Medical Center
Jun 8, 2021

Type2 Diabetes, Heart Failure With Reduced Ejection Fraction Trial in Hong Kong (Dapagliflozin)

Active, not recruiting
  • Type2 Diabetes
  • Heart Failure With Reduced Ejection Fraction
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Aug 2, 2021

Type2 Diabetes, Stable Coronary Artery Disease Trial in Rome (Dapagliflozin 10Mg Tab, Placebo)

Recruiting
  • Type2 Diabetes Mellitus
  • Stable Coronary Artery Disease
  • Dapagliflozin 10Mg Tab
  • Placebo
  • Rome, RM, Italy
    Center For Endocrine and Metabolic Diseases - Catholic Universit
Mar 1, 2021

Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)

Not yet recruiting
  • Lupus Nephritis
  • Chronic Kidney Diseases
  • Dapagliflozin 10mg Tab
  • Standard maintenance therapy
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 24, 2023

Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure Trial

Not yet recruiting
  • Heart Failure NYHA Class II
  • +2 more
    • (no location specified)
    May 22, 2023

    SGLT2 Inhibition in Heart Failure

    Recruiting
    • Heart Failure
    • Sodium-glucose cotransporter 2 inhibitor
    • Belfast, United Kingdom
      Belfast Health and Social Care Trust
    Nov 15, 2023

    Acute Kidney Injury, Kidney Failure, Sodium Glucose Cotransporter-2 Inhibitors Trial in Newtown (SGLT2 inhibitor or matched )

    Not yet recruiting
    • Acute Kidney Injury
    • +2 more
    • SGLT2 inhibitor or matched placebo
    • Newtown, New South Wales, Australia
      The George Institute for Global Health
    Jul 19, 2022

    Diabetes, Heart Failure Trial in Singapore (Dapagliflozin 10 MG [Forxiga])

    Completed
    • Diabetes Mellitus
    • Heart Failure
    • Dapagliflozin 10 MG [Forxiga]
    • Singapore, Singapore
      National Heart Centre Singapore
    Jan 13, 2023

    Nephropathy, Hypoxia, Mitochondrial Alteration Trial in Gentofte (Forxiga)

    Completed
    • Nephropathy
    • +4 more
    • Gentofte, Denmark
      Steno Diabetes Center Copenhagen
    Jan 29, 2021

    Obesity, Metabolic Syndrome Trial in Nashville (Empagliflozin 25 MG, Placebo)

    Not yet recruiting
    • Obesity
    • Metabolic Syndrome
    • Empagliflozin 25 MG
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 24, 2023

    Myocardial Infarction, Diabetes, Type 2, Myocardial Remodeling, Ventricular Trial in Cairo (Dapagliflozin 10Mg Tab)

    Recruiting
    • Myocardial Infarction
    • +2 more
    • Dapagliflozin 10Mg Tab
    • Cairo, Egypt
      Ain shams university hospitals
    Sep 20, 2022

    SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )

    Active, not recruiting
    • SLE
    • +2 more
    • Mansoura, Egypt
      Urology and Nephrology Center
    Feb 18, 2023

    Heart Failure Acute, Ventilator Lung Trial in Taipei (SGLT2 inhibitor)

    Recruiting
    • Heart Failure Acute
    • Ventilator Lung
    • SGLT2 inhibitor
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 16, 2023